• Peter Willinger succeeded Walter Miller as Heidelberg Pharma's chief financial officer effective May 1, 2026.
• Miller left at his own request at the end of April 2026 when his contract expired.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heidelberg Pharma AG published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2416152_en) on October 15, 2026, and is solely responsible for the information contained therein.